FDA Brief

Warning letters Drugs

FDA warning letter to

DermaRite Industries, LLC

High riskIssued Oct 27, 2025Posted Nov 18, 2025Center for Drug Evaluation and Research (CDER)

DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.

What happened

FDA inspected DermaRite's drug manufacturing facility in North Bergen, NJ, from March 26 to April 8, 2025. It found inadequate investigations when test results failed or were outside limits, missing identity tests on incoming components, an inadequate stability program, and weak quality-unit oversight. FDA also found five OTC topical products were unapproved new drugs and misbranded, and the firm recalled products that failed microbial tests and all water-containing lots.

What FDA found

  1. DermaRite failed to thoroughly investigate failed or out-of-limit test results and released batches after retesting until it got a passing result.

    21 CFR 211.192
  2. DermaRite failed to test each incoming component lot for identity and relied on supplier certificates of analysis without establishing their reliability.

    21 CFR 211.84(d)(1) and 211.84(d)(2)
  3. DermaRite lacked an adequate stability program, placed no OTC drugs on stability in 2023 or 2024, and had 2022 stability failures.

    21 CFR 211.166(a)
  4. DermaRite's quality control unit failed to provide adequate oversight, including annual product reviews and complete testing data in certificates of analysis.

    21 CFR 211.22; 21 CFR 211.180(e); 21 CFR 211.194(a)
  5. Five OTC topical drug products were introduced without FDA-approved applications.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  6. The five products were misbranded, and DermaMed Ointment was also misbranded for lacking adequate directions.

    FD&C Act sections 502(f)(1) and 502(ee), 21 U.S.C. 352(f)(1) and 352(ee)

What FDA wants

FDA asks DermaRite to provide independent reviews and remediation plans for its investigations, component testing, stability program, and quality unit, and to assess and act on products at risk; no response deadline is stated in the provided letter.

Who should pay attention

  • companies that buy OTC topical drugs from contract manufacturers
  • brands selling skin and wound care products
  • suppliers of glycerin, propylene glycol, or ethanol to drug makers

This is a summary. Read the original letter on fda.gov.

DermaRite Industries, LLC's FDA history

Recalls in the last 12 months

Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
Lantiseptic, Skin Protectant, Lanolin USP 30%, packaged in a) 5g (0.17 oz) (NDC 61924-304-05), b)14.2g (0.5 oz)( NDC 61924-304-14), c) 4oz (NDC 61924-304-04), d) 4.5oz (NDC 61924-304-45), and e) 12oz (NDC 61924-304-12) t…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
KleenFoam Antimicrobial Foam Soap, Chloroxylenol 0.5%, 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-093-34
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
DermaFungal, Antifungal Cream with 2% Miconazole Nitrate, packaged in a) 5 g (0.18 oz) per packet (NDC 61924-234-05), and b)106 g (3.75 oz.) per tube (NDC 61924-234-04) DermaRite Industries LLC, 7777 West Side Avenue, No…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
PeriGiene, Health Care Antiseptic, Chloroxylenol 0.5%, 222mL (7.5 fl. oz.) bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
DermaMed Ointment, Skin Protectant, Aluminum Hydroxide Gel 2%, Net Wt. 106 g (3.75 oz.) per tube, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-214-04
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
PeriGuard Ointment, Petrolatum 49.9%, packaged in a) 5g (NDC 61924-205-05), b) 3.5oz (NDC 61924-205-04), and c) 7oz (NDC 61924-205-07) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
Renew PeriProtect, Zinc Oxide 12%, Dimethicone 1%, 113g (4 oz.) per tube, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-435-04
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E, Chloroxylenol 0.2%, packaged in a) 222 mL (7.5 fl. oz.) per tube (NDC 61924-092-08), b) 800 mL (27 fl. oz.) per bag (NDC 61924-092-27), and c 1000 mL (34 fl.…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
San-E-Foam, Alcohol 67%, 1000 mL (34 fl. oz.) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-107-34
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate 15%, 118 mL (4 fl. oz.), DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-266-04
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
GelRite Instant Hand Sanitizer, Alcohol 65%, packaged in a) 118 mL (NDC 61924-106-04), b) 473 mL (NDC 61924-106-16) and c) 800 mL (NDC 61924-106-27), and d) 1000 mL (NDC 61924-106-34) per container, DermaRite Industries …
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
Hand-E-Foam, Benzethonium Chloride 0.20%, packaged in a) 236mL (NDC 61924-102-08) and b) 1000 mL (NDC 61924-102-34) per container, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
Renew Skin Repair Cream, Dimethicone 1.5%, packaged in a) 5g tube (NDC 61924-405-05), b) 4 oz tube (NDC 61924-405-04), and c) 800 mL (NDC 61924-405-27), DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 0…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Be…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
McKesson Skin Protectant, Lanolin USP, packaged in a) 5g (NDC 68599-6202-1), and b) 4oz NDC 68599-6203-4 tube, Distributed by McKesson Medical-Surgical Inc., Richmond, VA 23233.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
4-N-1 Skin Protectant, No Rinse Wash Cream with Dimethicone 1%, 113g, (4 oz) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-208-04
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Nov 26, 2025 Class II DermaRite Industries, LLC
Drug
DermaCerin, Skin Protectant Moisturizing Cream (petrolatum 33%), packaged in a) 106 g (3.75 oz.) per tube (NDC 61924-174-04) and b) 454 g (16 oz.) per jar (NDC 61924-174-16), DermaRite Industries LLC, 7777 West Side Aven…
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Full company page

Similar letters to other companies

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Shenzhen Benliju Biotech Co., Ltd.

    FDA: Shenzhen Benliju Biotech released OTC drugs labeled sterile without sterility testing or process validation.

    High risk
  3. LGM Pharma Solutions, LLC

    FDA warned LGM Pharma Solutions over manufacturing-quality failures in failing-result investigations and process validation for tablets, including a recalled product.

    High risk
  4. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk